BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 13, 2003
View Archived Issues
Anticytomegalovirus pyridazinones identified by Bayer researchers
Read More
New 5-HT1A receptor ligands discovered at Lundbeck
Read More
Aventis claims new KDR inhibitors obtained from natural source
Read More
New glucokinase activators under study at AstraZeneca
Read More
Novel antidiabetic agents identified at Dr. Reddy's Research Foundation
Read More
Advances in Alizyme product development portfolio
Read More
No effects on cerebral blood perfusion reported for pravastatin after acute stroke
Read More
Eptacog alfa in intracerebral hemorrhage
Read More
French team presents novel histamine H3 antagonists
Read More
8-Arylquinolines with PDE4-inhibitory activity in Merck pipeline
Read More
Neurocrine Biosciences reviews year of significant milestones
Read More
Midpoint enrollment reached in Oxytrex study
Read More
Progress at Myriad Genetics during second quarter of fiscal 2003
Read More
Isis achieves second milestone in Amgen antisense collaboration
Read More
Echelon Biosciences awarded grant for cancer and diabetes research
Read More
Encouraging results reported for Ontak in steroid-resistant acute GvHD
Read More
Phase II trial begins for ISS therapy for asthma
Read More
AMD-070 demonstrates promise as a new anti-HIV drug targeting CXCR4
Read More
Lorus Therapeutics and NCI to evaluate GTI-2040 in phase II trials
Read More
Phase II interim results for GI7DT plus chemotherapy in gastric cancer
Read More
Orally available CCR5 antagonist with promise as an anti-HIV candidate
Read More
Johnson & Johnson completes acquisition of OraPharma
Read More
Debiopharm forms collaboration with Tulane University
Read More
Clinically relevant therapeutic window seen for NXY-059 in primate acute stroke model
Read More
ImmunoGen highlights key advances in its product pipeline
Read More
New data for tenofovir DF plus lamivudine and efavirenz in antiretroviral-naive HIV patients
Read More
Evidence of antiretroviral efficacy reported for T-1249 in enfuvirtide-resistant HIV patients
Read More
Improved safety and pharmacokinetic profile reported for TMC-114 when combined with ritonavir
Read More